Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ProQR Therapeutics N.V. (PRQR): Jennison Associates Grabbed A Large Chunk Of This Biotech Stock

ProQR Therapeutics N.V. (NASDAQ:PRQR) is a tiny $134 million company with a daily trading volume of only $500 thousand. Yet, it managed to attract a 11.5% investment from Jennison Associates recently. Jennison isn’t the only healthcare investor with a large ProQR Therapeutics position either. Samuel Isaly’s OrbiMed had $20 million invested in the stock at the end of December. Another healthcare heavyweight, Baker Brothers, had nearly $9 million riding on this biotech stock. Even billionaires Israel Englander and Andreas Halvorsen have relatively large positions in the stock.

Overall, hedge funds tracked by Insider Monkey owned a quarter of ProQR Therapeutics’ shares at the end of December. Jennison’s new position is as of March 31st. The details of its filing can be found below:

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Jennison Associates 2,674,844 0 0 2,674,844 2,674,844 11.5%

Page 1 of 5 – SEC Filing

Securities and Exchange Commission

Washington, D.C. 20549

Schedule 13G

Under the Securities Exchange Act of 1934

(Amendment No. 0)*

March 31, 2016
(Date of event which requires filing of this statement)

Check the appropriate box to designate the rule pursuant to which

this schedule is filed:

(X) Rule 13d-1(b)

( ) Rule 13d-1(c)

( ) Rule 13d-1(d)

Name of Issuer: ProQR Therapeutics N.V.

Title of Class of Securities: Ordinary Shares

CUSIP Number: N71542109

*The remainder of this cover page shall be filled out for a

reporting person’s initial filing on this form with respect to

the subject class of securities, and for any subsequent

amendment containing information which would alter the

disclosures provided in a prior cover page.

The information required in the remainder of this cover page

shall not be deemed to be “filed” for the purpose of Section 18

of the Securities Exchange Act of 1934 (“Act”) or otherwise

subject to the liabilities of that section of the Act but shall

be subject to all other provisions of the Act (however, see the


Follow Proqr Therapeutics N.v. (NASDAQ:PRQR)
Trade (NASDAQ:PRQR) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.